These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9260075)

  • 1. Detection of neuropsychological impairment among substance-abusing patients: accuracy of the neurobehavioral cognitive status examination.
    Fals-Stewart W
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):269-76. PubMed ID: 9260075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module.
    Grohman K; Fals-Stewart W
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency.
    Fals-Stewart W
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):39-50. PubMed ID: 9234038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries.
    Fals-Stewart W
    J Subst Abuse; 1996; 8(1):1-17. PubMed ID: 8743765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of recently detoxified patients with alcoholism on a neuropsychological screening test.
    Zinn S; Bosworth HB; Edwards CL; Logue PE; Swartzwelder HS
    Addict Behav; 2003 Jul; 28(5):837-49. PubMed ID: 12788260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Neurobehavioral Cognitive Status Examination in the hospitalized elderly.
    Fields SD; Fulop G; Sachs CJ; Strain J; Fillit H
    Int Psychogeriatr; 1992; 4(1):93-102. PubMed ID: 1391676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neurobehavioral Cognitive Status Examination: comparison with the Cognitive Capacity Screening Examination and the Mini-Mental State Examination in a neurosurgical population.
    Schwamm LH; Van Dyke C; Kiernan RJ; Merrin EL; Mueller J
    Ann Intern Med; 1987 Oct; 107(4):486-91. PubMed ID: 3631787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation.
    Gillen RW; Kranzler HR; Kadden RM; Weidenman MA
    J Subst Abuse Treat; 1991; 8(4):247-51. PubMed ID: 1664866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment.
    Meek PS; Clark HW; Solana VL
    J Psychoactive Drugs; 1989; 21(2):153-60. PubMed ID: 2760756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuropsychological test performance of drug-abusing patients: an examination of latent cognitive abilities and associated risk factors.
    Fals-Stewart W; Bates ME
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):34-45. PubMed ID: 12622342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neurobehavioral Cognitive Status Examination: accuracy of the "screen-metric" approach in a clinical sample.
    Oehlert ME; Hass SD; Freeman MR; Williams MD; Ryan JJ; Sumerall SW
    J Clin Psychol; 1997 Nov; 53(7):733-7. PubMed ID: 9356903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent validity of the Neurobehavioral Cognitive Status Exam subtests.
    Marcotte TD; van Gorp W; Hinkin CH; Osato S
    J Clin Exp Neuropsychol; 1997 Jun; 19(3):386-95. PubMed ID: 9268813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment associated with cocaine use: The role of co-existent alcohol abuse/dependence.
    Blanco-Presas L; Moreno-Alcázar A; Alonso-Lana S; Salvador R; Pomarol-Clotet E; McKenna P
    Drug Alcohol Depend; 2018 Aug; 189():70-75. PubMed ID: 29886366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical evaluation of the Neurobehavioral Cognitive Status Examination in a general psychiatric inpatient population.
    Lamarre CJ; Patten SB
    J Psychiatry Neurosci; 1994 Mar; 19(2):103-8. PubMed ID: 8204561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of validity and reliability of the Neurobehavioral Cognitive Status Examination (NCSE) in assessment of psychiatric patients.
    Mitrushina M; Abara J; Blumenfeld A
    J Psychiatr Res; 1994; 28(1):85-95. PubMed ID: 8064643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of screening instruments in detecting substance use disorders among prisoners.
    Peters RH; Greenbaum PE; Steinberg ML; Carter CR; Ortiz MM; Fry BC; Valle SK
    J Subst Abuse Treat; 2000 Jun; 18(4):349-58. PubMed ID: 10812308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of substance abuse on visuographic function.
    Amir T; Bahri T
    Percept Mot Skills; 1994 Feb; 78(1):235-41. PubMed ID: 8177664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders.
    Rush B; Castel S; Brands B; Toneatto T; Veldhuizen S
    J Subst Abuse Treat; 2013 Apr; 44(4):375-83. PubMed ID: 23098381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment.
    Kiernan RJ; Mueller J; Langston JW; Van Dyke C
    Ann Intern Med; 1987 Oct; 107(4):481-5. PubMed ID: 3631786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.